G6PC1 and neoplasm: Gluconeogenesis, the reverse pathway of glycolysis, could antagonize tumor glycolysis depending on main enzymes, such as phosphoenolpyruvate carboxykinase (PCK), fructose-1,6-bisphosphatase (FBPase), and glucose-6-phosphatase (G6Pase).